Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.

作者: Sumit Isharwal , Hongying Huang , Gouri Nanjangud , François Audenet , Ying-Bei Chen

DOI: 10.1016/J.HUMPATH.2018.03.015

关键词: Fluorescence in situ hybridizationHistologyCancer researchProtein overexpressionImmunohistochemistryChemistryUrothelial carcinomaERBB2 AmplificationHer2 expressionNot Otherwise Specified

摘要: Micropapillary urothelial carcinoma (MPUC) is a rare but an aggressive variant of carcinoma. MPUC has been shown to commonly exhibit ERBB2 amplification and HER2 protein overexpression, the frequency distribution these findings within micropapillary (MP) not otherwise specified (NOS) components tumors with mixed histology have addressed. Therefore, we evaluated expression in 43 cases by fluorescence situ hybridization (FISH) immunohistochemistry (IHC). Of 35 containing both MP NOS components, was present 12 (34.3%), only component 11 (31.4%), exclusively 4 (11.4%). overexpression significantly more compared same tumor (68.6% versus 34.3%, P = .012). Overall, there moderately positive correlation between (ρ 0.59, < .001) 0.70, components. All MP/NOS areas IHC score 3+ none 0 were associated amplification. We conclude that are preferentially identified tumor. Our identify presence intratumoral heterogeneity provide grounds for further investigation into mechanisms underlying development MPUC.

参考文章(32)
Oscar Rodríguez-Faba, Josep M Gaya, Humberto Villavicencio, Joan Palou, Ferran Algaba, Jacobo Arce, The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ. Canadian Journal of Urology. ,vol. 17, pp. 5370- 5376 ,(2010)
Rocio Vicario, Vicente Peg, Beatriz Morancho, Mariano Zacarias-Fluck, Junjie Zhang, Águeda Martínez-Barriocanal, Alexandra Navarro Jiménez, Claudia Aura, Octavio Burgues, Ana Lluch, Javier Cortés, Paolo Nuciforo, Isabel T Rubio, Elisabetta Marangoni, James Deeds, Markus Boehm, Robert Schlegel, Josep Tabernero, Rebecca Mosher, Joaquín Arribas, None, Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies PLOS ONE. ,vol. 10, pp. e0129876- ,(2015) , 10.1371/JOURNAL.PONE.0129876
Joshua J. Meeks, Jennifer M. Taylor, Kazuhito Matsushita, Harry W. Herr, S. Machele Donat, Bernard H. Bochner, Guido Dalbagni, Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer BJU International. ,vol. 111, pp. E325- E330 ,(2013) , 10.1111/J.1464-410X.2012.11751.X
J. Tschui, E. Vassella, N. Bandi, U. Baumgartner, V. Genitsch, D. Rotzer, R. Seiler, G. N. Thalmann, A. Fleischmann, Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer Virchows Archiv. ,vol. 466, pp. 703- 710 ,(2015) , 10.1007/S00428-015-1729-4
Islam A. Ghoneim, Ranko Miocinovic, Andrew J. Stephenson, Jorge A. Garcia, Michael C. Gong, Steven C. Campbell, Donna E. Hansel, Amr F. Fergany, Neoadjuvant Systemic Therapy or Early Cystectomy? Single-center Analysis of Outcomes After Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder Urology. ,vol. 77, pp. 867- 870 ,(2011) , 10.1016/J.UROLOGY.2010.11.043
Pamela L. Kunz, Amirkaveh Mojtahed, George A. Fisher, James M. Ford, Daniel T. Chang, Raymond R. Balise, Charles D. Bangs, Athena M. Cherry, Reetesh K. Pai, HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment. Applied Immunohistochemistry & Molecular Morphology. ,vol. 20, pp. 13- 24 ,(2012) , 10.1097/PAI.0B013E31821C821C
Efsevia Vakiani, HER2 testing in gastric and gastroesophageal adenocarcinomas. Advances in Anatomic Pathology. ,vol. 22, pp. 194- 201 ,(2015) , 10.1097/PAP.0000000000000067
Ashish M. Kamat, Colin P. N. Dinney, Jason R. Gee, H. Barton Grossman, Arlene O. Siefker-Radtke, Pheroze Tamboli, Michelle A. Detry, Tracy L. Robinson, Louis L. Pisters, Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. ,vol. 110, pp. 62- 67 ,(2007) , 10.1002/CNCR.22756
Steven A Schneider, William R Sukov, Igor Frank, Stephen A Boorjian, Brian A Costello, Robert F Tarrell, Prabin Thapa, R Houston Thompson, Matthew K Tollefson, R Jeffrey Karnes, John C Cheville, Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. Modern Pathology. ,vol. 27, pp. 758- 764 ,(2014) , 10.1038/MODPATHOL.2013.201
Jeffrey K. Wang, Stephen A. Boorjian, John C. Cheville, Simon P. Kim, Robert F. Tarrell, Prabin Thapa, Igor Frank, Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis World Journal of Urology. ,vol. 30, pp. 801- 806 ,(2012) , 10.1007/S00345-012-0976-0